ArticleFrontiers in oncology2023

Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment.

Hyun Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.